ADAR1 Capital Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.44M Sell
57,100
-259,839
-82% -$11.6M 0.11% 133
2026
Q1
$15.3M Buy
316,939
+253,465
+399% +$11.8M 0.9% 23
2025
Q4
$3.08M Sell
63,474
-10,738
-14% -$532K 0.23% 77
2025
Q3
$3.5M Buy
74,212
+64,212
+642% +$3.1M 0.33% 58
2025
Q2
$483K Buy
+10,000
New +$511K 0.07% 120
2025
Q1
Sell
-99,600
Closed -$4.8M 248
2024
Q4
$4.8M Buy
+99,600
New +$5.06M 0.96% 27
2024
Q3
Sell
-9,100
Closed -$442K 334
2024
Q2
$442K Buy
9,100
+3,600
+65% +$174K 0.08% 106
2024
Q1
$267K Buy
+5,500
New +$269K 0.06% 108

Other funds holding SNY

ADAR1 Capital Management's SNY Position: Q2 2026 in Review

ADAR1 Capital Management reduced its Sanofi (SNY) stake by 82% in Q2 2026, selling an estimated $11.6M and leaving 57,100 shares worth $2.44M. The position accounts for 0.11% of the portfolio, ranked #133.

ADAR1 Capital Management first reported a position in SNY in Q1 2024 and has held it in 8 quarters since. The position peaked at $15.3M in Q1 2026. 714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • ADAR1 Capital Management held 57,100 shares of Sanofi worth $2.44M as of Q2 2026.
  • ADAR1 Capital Management sold 259,839 Sanofi shares in Q2 2026, an estimated $11.6M.
  • Sanofi made up 0.11% of ADAR1 Capital Management's portfolio in Q2 2026, its #133 holding.
  • ADAR1 Capital Management first reported a position in Sanofi in Q1 2024 and has held it in 8 quarters since.
  • ADAR1 Capital Management's Sanofi position peaked at $15.3M in Q1 2026.
  • 714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.